| Financial Year |
March 31 2023 |
| Monetary Funds |
4,169,495,992.99 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
178,313,280.71 |
| Accounts Receivable |
4,044,762,599.58 |
| Advances to Suppliers |
1,574,663,640.78 |
| Other Receivables |
27,974,921.31 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
13,050,366,107.82 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
120,324,075.77 |
| Total Current Assets |
24,090,738,976.57 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
30,003,773.05 |
| Investment Properties |
85,331,591.50 |
| Fixed Assetes |
1,738,711,224.73 |
| Under-construction Projects |
81,409,175.60 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
499,527,044.24 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
133,962,264.13 |
| Deferred Income Tax Assets |
201,480,401.04 |
| Other Non-Current Assets |
255,511,605.43 |
| Sub-Total of Non-Current Assets |
3,520,192,180.57 |
| Total Assets |
27,610,931,157.14 |
| Short-Term Loans |
1,042,702,333.32 |
| Trading Financial liabilities |
-- |
| Notes Payable |
3,019,641,787.55 |
| Accounts Payable |
10,616,554,351.51 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
81,126,157.14 |
| Taxes Payable |
169,747,980.84 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
112,668,019.18 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
153,253,986.11 |
| Other Current Liabilities |
8,966,982.42 |
| Sub-Total of Current Liabilities |
16,583,533,664.02 |
| Long-term Loans |
118,040,000.56 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-73,477,688.74 |
| Special Payable |
-- |
| Estimatied Liabilities |
408,704,954.93 |
| Deferred Income Tax Liabilities |
51,704,507.11 |
| Other Non-Current Liabilities |
67,467,737.50 |
| Sub-Total of Non-Current Liabilities |
963,182,934.18 |
| Total Liabilities |
17,546,716,598.20 |
| Paid-In Capital(Or Share Stock) |
589,476,716.00 |
| Capital Surplus |
4,421,655,931.86 |
| Surplus Reserve |
414,102,054.90 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,041,725,697.18 |
| Minority Stockholder's Interest |
298,924,465.07 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
9,765,290,093.87 |
| Owner's Equity（Stockholder's Equity） |
10,064,214,558.94 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
27,610,931,157.14 |
